Uncover the role of IL-4 and its potency in inducing B-cell activation in type 2 inflammatory diseases – a soundbite from the ESDR Symposium 2022.
In this soundbite from the ESDR symposium in 2022, Prof. Lisa Beck, MD (University of Rochester, USA), explains the importance of interleukin 4 in type 2 inflammation and its potency in inducing B-cell activation compared to interleukin 13.
Goldsmith Professor of Dermatology, University of Rochester Medical Center, New York, United States
See author’s profile